Joseph Baroldi - Jan 31, 2022 Form 3 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Chief Business Officer
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Joseph T. Baroldi
Stock symbol
IONS
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
3
Date filed
2/2/2022, 06:26 PM
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IONS Common Stock 3.61K Jan 31, 2022 Direct
holding IONS Common Stock 322 Jan 31, 2022 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IONS Non-Qualified Stock Option (right to buy) Jan 31, 2022 Common Stock 2.85K $32.60 by Spouse F1
holding IONS Non-Qualified Stock Option (right to buy) Jan 31, 2022 Common Stock 4.92K $56.78 by Spouse F2
holding IONS Restricted Stock Unit Jan 31, 2022 Common Stock 3.07K $0.00 by Spouse F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant on 01/03/2022 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 01/03/2023. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments, at a rate of 712 shares per year. The option is exercisable as to 0 shares on 01/31/2022.
F2 Grant on 01/04/2021 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 01/04/2022. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments, at a rate of 1,231 shares per year. The option is exercisable as to 1,231 shares on 01/31/2022.
F3 Grants to reporting person's spouse of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan on January 15, 2021 and January 15, 2022. The restricted stock units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.